Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8737899rdf:typepubmed:Citationlld:pubmed
pubmed-article:8737899lifeskim:mentionsumls-concept:C0009649lld:lifeskim
pubmed-article:8737899lifeskim:mentionsumls-concept:C0037993lld:lifeskim
pubmed-article:8737899lifeskim:mentionsumls-concept:C0010124lld:lifeskim
pubmed-article:8737899lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:8737899lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8737899lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:8737899lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:8737899lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:8737899lifeskim:mentionsumls-concept:C1819447lld:lifeskim
pubmed-article:8737899pubmed:issue6lld:pubmed
pubmed-article:8737899pubmed:dateCreated1996-11-8lld:pubmed
pubmed-article:8737899pubmed:abstractTextThe present study used a taste aversion paradigm to condition lipopolysaccharide (LPS)-induced suppression of splenic lymphocyte interleukin-2 (IL-2) production, with concurrent measurement of corticosterone production and splenic norepinephrine (NE) content). In training, two groups of rats received saccharin and IP LPS in a paired (P) manner and a third group in a specifically unpaired (U) manner. In the test, the unpaired group (group U) and one of the paired (group P) groups were re-exposed (R) to the cue and the other not (NR). An additional group controlled for the effects of cues (conditional stimulus) and fluid deprivation (negative control; NC). A robust taste aversion in the P-R group was accompanied by suppression of IL-2 production, reduced splenic NE content, and elevated corticosterone production, relative to combined controls (i.e., groups U-R, P-NR, and NC). The conditioned modulation of IL-2 secretion, along with the concomitant alteration of adrenocortical and sympathetic mediators, supports the involvement of bidirectional central nervous-immune system pathways in this paradigm.lld:pubmed
pubmed-article:8737899pubmed:languageenglld:pubmed
pubmed-article:8737899pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8737899pubmed:citationSubsetIMlld:pubmed
pubmed-article:8737899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8737899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8737899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8737899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8737899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8737899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8737899pubmed:statusMEDLINElld:pubmed
pubmed-article:8737899pubmed:monthJunlld:pubmed
pubmed-article:8737899pubmed:issn0031-9384lld:pubmed
pubmed-article:8737899pubmed:authorpubmed-author:MurrayLLlld:pubmed
pubmed-article:8737899pubmed:authorpubmed-author:NanceD MDMlld:pubmed
pubmed-article:8737899pubmed:authorpubmed-author:GreenbergA...lld:pubmed
pubmed-article:8737899pubmed:authorpubmed-author:HARTMMlld:pubmed
pubmed-article:8737899pubmed:authorpubmed-author:VriendC YCYlld:pubmed
pubmed-article:8737899pubmed:authorpubmed-author:JanzL JLJlld:pubmed
pubmed-article:8737899pubmed:authorpubmed-author:Green-Johnson...lld:pubmed
pubmed-article:8737899pubmed:issnTypePrintlld:pubmed
pubmed-article:8737899pubmed:volume59lld:pubmed
pubmed-article:8737899pubmed:ownerNLMlld:pubmed
pubmed-article:8737899pubmed:authorsCompleteYlld:pubmed
pubmed-article:8737899pubmed:pagination1103-9lld:pubmed
pubmed-article:8737899pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:meshHeadingpubmed-meshheading:8737899-...lld:pubmed
pubmed-article:8737899pubmed:year1996lld:pubmed
pubmed-article:8737899pubmed:articleTitlePavlovian conditioning of LPS-induced responses: effects on corticosterone, splenic NE, and IL-2 production.lld:pubmed
pubmed-article:8737899pubmed:affiliationDepartment of Pathology, University of Manitoba, Winnipeg, Canada.lld:pubmed
pubmed-article:8737899pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8737899lld:pubmed